Brain activity linked to TNF inhibitor response in RA

Brain activity linked to TNF inhibitor response in RA
Patients with rheumatoid arthritis who respond to tumor necrosis factor inhibitors show changes in activity in pain-related areas of the brain before clinical signs of improvement are observed, according to a study published in the February issue of Arthritis & Rheumatism.

(HealthDay)—Patients with rheumatoid arthritis who respond to tumor necrosis factor inhibitors (TNFi) show changes in activity in pain-related areas of the brain before clinical signs of improvement are observed, according to a study published in the February issue of Arthritis & Rheumatism.

Juergen Rech, M.D., from the University of Erlangen-Nuremberg in Germany, and colleagues performed functional magnetic resonance imaging (MRI) of the and anatomic MRI of the hand in 10 patients with active rheumatoid before and up to 28 days after starting treatment with TNFi.

The researchers found that patients who responded to TNFi had a greater mean decrease in Disease Activity Score in 28 joints 28 days after starting treatment. Responders had greater activation of the thalamic, limbic, and associative areas of the brain, which decreased within three days of starting treatment. This was followed by clinical responses after seven days and responses on the hand MRI 28 days after starting treatment.

"These data suggest that response to TNFi depends on brain activity in patients, reflecting the subjective perception of disease," Rech and colleagues conclude.

One author disclosed receiving speaking fees from several pharmaceutical companies.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Bring the feet when diagnosing, treating rheumatoid arthritis

Dec 07, 2011

When diagnosing and treating patients with rheumatoid arthritis (RA), clinical research focuses primarily on the joints in the upper body. However, research carried out by rheumatologist Hetty Baan at the University of Twente ...

Data suggest smoking doesn't impact RA treatment response

Dec 21, 2012

(HealthDay)—For patients with early rheumatoid arthritis (RA), smoking status does not impact treatment response to early combination therapy or initial methotrexate treatment with step-up therapy, according ...

Recommended for you

Cartilage actively contributes to arthritis

Sep 12, 2014

Melbourne researchers have discovered that cartilage plays an active role in the destruction and remodelling of joints seen in rheumatoid arthritis, rather than being an 'innocent bystander' as previously ...

Blocking one receptor could halt rheumatoid arthritis

Sep 10, 2014

Researchers at the University of Illinois at Chicago College of Medicine have shown for the first time how the activation of a receptor provokes the inflammation and bone degradation of rheumatoid arthritis—and ...

User comments